The Endless Saga of Monocyte Diversity.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 17 05 2019
accepted: 16 07 2019
entrez: 27 8 2019
pubmed: 27 8 2019
medline: 22 10 2020
Statut: epublish

Résumé

Cancer immunotherapy relies on either restoring or activating the function of adaptive immune cells, mainly CD8

Identifiants

pubmed: 31447834
doi: 10.3389/fimmu.2019.01786
pmc: PMC6691342
doi:

Substances chimiques

CCAAT-Enhancer-Binding Protein-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1786

Références

Clin Cancer Res. 1999 Oct;5(10):2963-70
pubmed: 10537366
J Immunol. 2000 Nov 1;165(9):5245-54
pubmed: 11046058
Hum Immunol. 2001 Nov;62(11):1282-93
pubmed: 11704292
J Cell Biol. 2002 Apr 29;157(3):493-507
pubmed: 11970960
J Immunol Methods. 2003 Feb;273(1-2):83-101
pubmed: 12535800
Immunity. 2003 Jul;19(1):71-82
pubmed: 12871640
Clin Cancer Res. 2003 Aug 1;9(8):2893-7
pubmed: 12912933
J Exp Med. 2003 Dec 15;198(12):1875-86
pubmed: 14676299
Cancer Res. 2004 Sep 1;64(17):6337-43
pubmed: 15342423
Cancer Cell. 2004 Oct;6(4):409-21
pubmed: 15488763
J Exp Med. 2005 Jan 17;201(2):221-31
pubmed: 15657291
J Exp Med. 2005 Oct 3;202(7):931-9
pubmed: 16186186
Nat Rev Immunol. 2005 Dec;5(12):953-64
pubmed: 16322748
Nat Immunol. 2006 Mar;7(3):311-7
pubmed: 16462739
N Engl J Med. 2006 Feb 9;354(6):610-21
pubmed: 16467548
Blood. 2006 Aug 15;108(4):1223-9
pubmed: 16645168
Nat Immunol. 2006 Jul;7(7):732-9
pubmed: 16751774
Eur J Biochem. 1991 Oct 1;201(1):113-7
pubmed: 1680678
Immunobiology. 2006;211(6-8):609-18
pubmed: 16920499
Cancer Res. 2006 Sep 15;66(18):9290-8
pubmed: 16982774
J Immunol. 2007 Apr 1;178(7):4022-6
pubmed: 17371955
Oncogene. 2008 Jan 24;27(5):663-74
pubmed: 17667938
Science. 2007 Aug 3;317(5838):666-70
pubmed: 17673663
Cancer Res. 2007 Nov 15;67(22):11021-8
pubmed: 18006848
Glycoconj J. 2008 Jul;25(5):415-25
pubmed: 18161023
Cancer Cell. 2008 Jan;13(1):23-35
pubmed: 18167337
Nat Immunol. 2008 Jun;9(6):632-40
pubmed: 18438410
AMIA Annu Symp Proc. 2007 Oct 11;:666-70
pubmed: 18693920
Nat Immunol. 2008 Dec;9(12):1341-6
pubmed: 18931678
Nat Immunol. 2008 Dec;9(12):1347-55
pubmed: 18997793
N Engl J Med. 2008 Dec 25;359(26):2814-23
pubmed: 19109576
Annu Rev Immunol. 2009;27:485-517
pubmed: 19132915
Annu Rev Immunol. 2009;27:669-92
pubmed: 19132917
Clin Cancer Res. 2009 Feb 1;15(3):778-87
pubmed: 19188147
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
J Immunol. 2009 May 15;182(10):6562-8
pubmed: 19414811
Cell. 2009 Jul 10;138(1):114-28
pubmed: 19596239
Curr Opin Pharmacol. 2009 Aug;9(4):470-81
pubmed: 19616475
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Cancer Res. 2010 Jan 1;70(1):68-77
pubmed: 20028852
Immunity. 2010 Mar 26;32(3):317-28
pubmed: 20206554
Cancer Res. 2010 Apr 15;70(8):3052-61
pubmed: 20388795
J Cell Biol. 2010 Apr 19;189(2):223-32
pubmed: 20404108
Science. 2010 Jun 25;328(5986):1689-93
pubmed: 20488992
J Leukoc Biol. 2010 Nov;88(5):839-48
pubmed: 20587738
Immunity. 2010 Jun 25;32(6):790-802
pubmed: 20605485
Nat Med. 2010 Aug;16(8):880-6
pubmed: 20622859
Immunity. 2010 Sep 24;33(3):375-86
pubmed: 20832340
Cancer Res. 2010 Oct 1;70(19):7465-75
pubmed: 20841473
Scand J Immunol. 2010 Dec;72(6):540-7
pubmed: 21044128
Trends Immunol. 2011 Jan;32(1):19-25
pubmed: 21067974
Cancer Res. 2011 Apr 1;71(7):2664-74
pubmed: 21324923
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
Nat Immunol. 2011 Jul 03;12(8):778-85
pubmed: 21725321
J Exp Med. 2011 Sep 26;208(10):1949-62
pubmed: 21930770
J Int Med Res. 2011;39(4):1381-91
pubmed: 21986138
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
Cancer Cell. 2011 Oct 18;20(4):538-49
pubmed: 22014578
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Structure. 2011 Nov 9;19(11):1543-8
pubmed: 22078554
Clin Immunol. 2012 May;143(2):162-9
pubmed: 22397822
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
Nat Med. 2012 Aug;18(8):1254-61
pubmed: 22842478
Cell Host Microbe. 2012 Aug 16;12(2):223-32
pubmed: 22901542
Cell Rep. 2012 Sep 27;2(3):628-39
pubmed: 22959433
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Exp Oncol. 2012 Oct;34(3):176-84
pubmed: 23070002
Cancer Sci. 2013 Jan;104(1):22-7
pubmed: 23181987
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Blood. 2013 Mar 7;121(10):1839-49
pubmed: 23319570
Cell. 2013 Jan 17;152(1-2):157-71
pubmed: 23332752
J Immunol. 2013 Mar 1;190(5):2403-14
pubmed: 23355732
Transplant Res. 2012 Sep 28;1(1):15
pubmed: 23369567
Nat Cell Biol. 2013 Mar;15(3):284-94
pubmed: 23396050
Diabetol Metab Syndr. 2013 Feb 15;5(1):6
pubmed: 23415113
Cancer Res. 2013 May 1;73(9):2782-94
pubmed: 23418320
J Clin Invest. 2013 Apr;123(4):1580-9
pubmed: 23454751
Cell. 2013 Apr 11;153(2):362-75
pubmed: 23582326
Immunity. 2013 Apr 18;38(4):633-43
pubmed: 23601682
Nat Commun. 2013;4:2035
pubmed: 23792809
Nat Immunol. 2013 Aug;14(8):812-20
pubmed: 23812099
Trends Immunol. 2013 Sep;34(9):440-5
pubmed: 23831267
Mol Cell. 2013 Aug 8;51(3):310-25
pubmed: 23932714
Nat Immunol. 2013 Oct;14(10):1045-53
pubmed: 23995233
Nat Rev Cancer. 2013 Oct;13(10):739-52
pubmed: 24060865
Adv Immunol. 2013;120:69-103
pubmed: 24070381
J Exp Med. 2013 Nov 18;210(12):2611-25
pubmed: 24166715
Annu Rev Immunol. 2014;32:51-82
pubmed: 24313777
Nat Rev Urol. 2014 Mar;11(3):153-62
pubmed: 24492433
Clin Vaccine Immunol. 2014 Apr;21(4):534-45
pubmed: 24521784
Front Immunol. 2014 Feb 24;5:69
pubmed: 24605112
Cancer Immunol Immunother. 2014 May;63(5):513-28
pubmed: 24652403
PLoS One. 2014 Apr 21;9(4):e95784
pubmed: 24752325
J Immunol. 2014 Jun 15;192(12):5821-9
pubmed: 24808361
Nat Rev Immunol. 2014 Jun;14(6):392-404
pubmed: 24854589
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8
pubmed: 24903093
Nature. 2014 Jun 19;510(7505):407-411
pubmed: 24919154
Cancer Res. 2014 Sep 15;74(18):5057-69
pubmed: 25082815
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Nat Cell Biol. 2014 Nov;16(11):1105-17
pubmed: 25266422
Nature. 2014 Nov 6;515(7525):130-3
pubmed: 25337873
PLoS Pathog. 2014 Oct 30;10(10):e1004485
pubmed: 25356988
Int J Cancer. 2015 Oct 1;137(7):1630-42
pubmed: 25802036
Blood. 2015 Jun 4;125(23):3618-26
pubmed: 25852055
Annu Rev Immunol. 2015;33:643-75
pubmed: 25861979
Biotechnol Appl Biochem. 1989 Dec;11(6):602-9
pubmed: 2597357
Cancer Immunol Res. 2015 Nov;3(11):1236-47
pubmed: 26025381
Oncoimmunology. 2015 Jan 22;4(4):e998107
pubmed: 26137411
Cancer Res. 2016 Jan 1;76(1):35-42
pubmed: 26573801
Nat Immunol. 2016 Jan;17(1):26-33
pubmed: 26681459
Oncotarget. 2016 Jan 12;7(2):1168-84
pubmed: 26700461
Oncotarget. 2016 May 10;7(19):28697-710
pubmed: 26885690
Blood. 2016 Jun 16;127(24):2991-3003
pubmed: 26966090
Immunity. 2016 Apr 19;44(4):755-68
pubmed: 26992565
Nat Cell Biol. 2016 Apr;18(4):356-65
pubmed: 27027486
Sci Transl Med. 2016 Apr 13;8(334):334ra52
pubmed: 27075626
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Semin Immunol. 2016 Aug;28(4):384-93
pubmed: 27113267
Cancer Discov. 2016 Aug;6(8):870-85
pubmed: 27179037
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337449
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25
pubmed: 27461391
Nat Commun. 2016 Aug 31;7:12597
pubmed: 27576369
Cancer Cell. 2016 Sep 12;30(3):377-390
pubmed: 27622331
Nature. 2016 Nov 17;539(7629):437-442
pubmed: 27642729
Immunity. 2016 Nov 15;45(5):975-987
pubmed: 27814941
J Am Heart Assoc. 2016 Nov 7;5(11):
pubmed: 27821400
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Cell Metab. 2016 Dec 13;24(6):807-819
pubmed: 27866838
Int J Cancer. 2017 Mar 15;140(6):1370-1383
pubmed: 27885671
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Nature. 2017 Jan 5;541(7635):96-101
pubmed: 28002407
J Immunol. 2017 Feb 1;198(3):999-1005
pubmed: 28115589
Oncoimmunology. 2016 Nov 2;6(1):e1252013
pubmed: 28197368
Immunity. 2017 Feb 21;46(2):233-244
pubmed: 28214225
Nature. 2017 Mar 30;543(7647):728-732
pubmed: 28321130
Nat Rev Mol Cell Biol. 2017 Jun;18(6):361-374
pubmed: 28356571
Sci Rep. 2017 Mar 30;7:45593
pubmed: 28358049
Cancer Res. 2017 May 15;77(10):2607-2619
pubmed: 28364000
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Immunity. 2017 May 16;46(5):764-766
pubmed: 28514680
Immunity. 2017 May 16;46(5):849-862.e7
pubmed: 28514690
Curr Opin Pharmacol. 2017 Aug;35:30-39
pubmed: 28554057
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
Cell Metab. 2017 Jul 5;26(1):142-156
pubmed: 28683282
J Immunother Cancer. 2017 Jul 18;5(1):53
pubmed: 28716061
Nat Commun. 2017 Sep 11;8(1):517
pubmed: 28894087
Semin Immunopathol. 2018 Feb;40(2):203-214
pubmed: 28971272
Nat Commun. 2017 Nov 6;8(1):1319
pubmed: 29105655
Oncotarget. 2017 Aug 7;8(45):78598-78613
pubmed: 29108252
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
Immunity. 2017 Nov 21;47(5):890-902.e4
pubmed: 29166589
Semin Immunol. 2018 Feb;35:12-18
pubmed: 29290545
Cell. 2018 Jan 11;172(1-2):135-146.e9
pubmed: 29328908
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
Cell. 2018 Jan 11;172(1-2):162-175.e14
pubmed: 29328911
Immunity. 2018 Jan 16;48(1):91-106.e6
pubmed: 29343444
Cell Immunol. 2018 Aug;330:43-53
pubmed: 29463401
J Leukoc Biol. 2018 Mar 30;:null
pubmed: 29603382
Oncoimmunology. 2018 Jan 16;7(4):e1412909
pubmed: 29632728
J Exp Med. 2018 Jun 4;215(6):1627-1647
pubmed: 29643186
Curr Opin Pharmacol. 2018 Aug;41:52-58
pubmed: 29702467
Front Immunol. 2018 Apr 30;9:869
pubmed: 29760700
Nat Med. 2018 Jun;24(6):739-748
pubmed: 29808007
Cancer Immunol Res. 2018 Sep;6(9):1046-1056
pubmed: 30002156
Cell Metab. 2019 Jan 8;29(1):211-220.e5
pubmed: 30293776
Immunity. 2018 Oct 16;49(4):595-613
pubmed: 30332628
JCI Insight. 2018 Oct 18;3(20):
pubmed: 30333313
J Exp Med. 2018 Nov 5;215(11):2725-2736
pubmed: 30355614
Biochem Pharmacol. 1987 May 15;36(10):1741-7
pubmed: 3036155
Cell Rep. 2018 Oct 30;25(5):1118-1126
pubmed: 30380404
Nat Commun. 2018 Dec 5;9(1):5193
pubmed: 30518925
Nat Rev Immunol. 2019 Jun;19(6):369-382
pubmed: 30718830
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Minerva Endocrinol. 1988 Jan-Mar;13(1):63-6
pubmed: 3367892
J Immunol. 1995 Nov 1;155(9):4330-8
pubmed: 7594592
Science. 1994 Sep 9;265(5178):1573-7
pubmed: 8079170
Mol Cell Biol. 1994 Jan;14(1):373-81
pubmed: 8264604
Breast Cancer Res Treat. 1996;39(3):275-83
pubmed: 8877007
EMBO J. 1996 Oct 15;15(20):5647-58
pubmed: 8896458
Mol Cell Biol. 1998 Jul;18(7):4301-14
pubmed: 9632814

Auteurs

Stefania Canè (S)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Stefano Ugel (S)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Rosalinda Trovato (R)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Ilaria Marigo (I)

Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Francesco De Sanctis (F)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Silvia Sartoris (S)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Vincenzo Bronte (V)

Section of Immunology, Department of Medicine, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH